DEFA14A: Duos Technologies Group Updates Proxy Statement Following Warrant Exercise and Preferred Stock Conversion Price Adjustment

Duos Technologies Group amends its proxy statement to reflect the issuance of common stock upon warrant exercise and a subsequent reduction in the conversion price of its Series E Preferred Stock.

Summary

• Duos Technologies Group has issued a supplement to its definitive proxy statement related to the upcoming Annual Meeting of Shareholders on September 30, 2024.
• The supplement addresses the issuance of 344,644 shares of Common Stock following the exercise of warrants by 21 April Fund LP and 21 April Fund Ltd.
• The exercise price of the warrants was reduced to $2.61 per share, and any 'blocker' provisions were removed.
• Holders of the Series E Preferred Stock consented to the issuance of Common Stock at $2.61, leading to a reduction in the conversion price of the Series E Preferred Stock from $3.00 to $2.61.
• The shares issued upon exercise of the warrants cannot be voted at the Annual Meeting because they were issued after the record date.
• The decrease in the conversion price of the Series E Preferred Stock affects the disclosure in the Proxy Statement regarding Proposal No. 3 (Securities Issuance Proposal).
• The 13,625 outstanding shares of Series E Preferred Stock are now convertible into 5,220,307 shares of Common Stock, up from the previously stated 4,541,667 shares.
• If all authorized shares of Series E Preferred Stock were issued, they would be convertible into 11,494,253 shares of Common Stock, instead of the previously stated 10,000,000 shares.
• The adjusted fully-diluted number, as discussed in Proposal No. 5, also increases due to the decrease in the conversion price of the Series E Preferred Stock.
• If Proposal No. 3 is approved, the limitation on convertibility of the Series E Preferred Stock will be removed, resulting in an adjusted fully-diluted number of 2,675,322.

Sentiment

Score: 5

Explanation: The document is a factual update regarding corporate actions. It doesn't contain overtly positive or negative information, hence a neutral sentiment score.

Positives

• The warrant exercise provides Duos Technologies with additional capital.
• The reduction in the conversion price of the Series E Preferred Stock could potentially simplify the capital structure.

Negatives

• The issuance of new shares dilutes existing shareholders.
• The reduction in the conversion price of the Series E Preferred Stock further increases potential dilution.

Risks

• Increased potential dilution from the conversion of Series E Preferred Stock could negatively impact share value.
• The adjusted fully-diluted number increasing could impact future equity incentive plans.

Future Outlook

The company currently has no plans to issue more shares of Series E Preferred Stock.

Industry Context

This announcement reflects common corporate finance activities such as warrant exercises and adjustments to preferred stock conversion prices, which are often used to manage capital structure and incentivize investment.

Comparison to Industry Standards

• Warrant exercises and preferred stock conversions are standard financial mechanisms used by companies, particularly smaller ones, to raise capital and manage their equity structure.
• The specific terms, such as the exercise price and conversion ratios, are negotiated based on the company's financial condition and market conditions at the time of the agreement.
• Similar transactions can be observed in other publicly traded companies, especially those in growth phases or undergoing restructuring.

Stakeholder Impact

• Shareholders may experience dilution due to the issuance of new shares.
• Holders of Series E Preferred Stock benefit from the reduced conversion price.

Next Steps

• Shareholders should review the updated information in the supplement before voting at the Annual Meeting on September 30, 2024.

Key Dates

Keywords

proxy statement, Series E Preferred Stock, warrants, conversion price, common stock, dilution, Duos Technologies